Novotech Awarded the Asia Pacific CRO of the Year 2022 for Best Practices in Clinical Trials
05 déc. 2022 14h44 HE
|
Novotech
SINGAPORE, Dec. 05, 2022 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific biotech specialist CRO, has been awarded the Frost & Sullivan Company of the Year Award 2022 for Best Practices in...
Clinical Research Opportunities in China and the Path to USFDA Approval – Whitepaper
30 oct. 2022 18h10 HE
|
Novotech
SYDNEY, Australia, Oct. 30, 2022 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific biotech specialist CRO, and GlobalData have published the latest China biotech landscape analysis with expert...